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INTRODUCTION
Due to the introduction of vaccination program and the ad-
vance of public health, tetanus is now uncommon in the devel-
oped countries. In Korea, a nationwide childhood vaccination
with tetanus toxoid began in 1956 and the improved wound
management have resulted in a decrease of tetanus (1). While
major efforts have been made to increase immunization cov-
erage among children, very little attention has been paid to
immunization against tetanus among adults. Thus, the risk
of tetanus may increase with age.
Recently, physicians might not have had a chance to take
care of tetanus patients due to a decreasing number of tetanus
cases in the developed countries, as well as in Korea. As a result,
tetanus may not be diagnosed adequately during the early stage
and therefore, proper treatment for tetanus can be delayed. To
our knowledge, there have been no documented reports about
spectrum of tetanus recently occurred in Korea. In this report,
we describe the demographics, epidemiological and clinical
findings, management, and outcome of 17 tetanus patients
who presented to Chonnam National University Hospital dur-
ing a 21-month period.
MATERIALS AND METHODS
During the periods of March 2000 and November 2001, 17
cases of tetanus were diagnosed at Chonnam National Uni-
versity Hospital, a 900-bed university-affiliated teaching
hospital in Korea. 
All cases of tetanus were clinically diagnosed, based on the
clinical case definition for public health surveillance for tetanus,
because a laboratory test for definitive diagnosis of tetanus was
not routinely available. Tetanus is defined as an acute onset of
hypertonia and/or painful muscular contractions, usually of
the muscles of the jaw and neck, and generalized muscle spasms
without other apparent medical cause (2). A chart review of
the demographic characteristics, epidemiology, occupational
and immunization history, symptoms and signs, treatment,
and outcome of 17 cases of tetanus were studied. In addition,
we reviewed the provisional diagnosis in order to find out
whether the first physicians were aware of tetanus in emer-
gency room.
RESULTS
Patient characteristics
During a 21-month period, we identified 17 adult tetanus.
Demographic characteristics, epidemiologic and clinical fea-
tures, and clinical outcome for all study subjects are summa-
rized in Table 1 and 2. The mean age of the 17 patients was
63 yr (range, 29-87). There were 5 (30%) males and 12 (70%)
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Recently Occurring Adult Tetanus in Korea: Emphasis on 
Immunization and Awareness of Tetanus 
Since a nationwide childhood vaccination with tetanus toxoid, tetanus has become
a rare disease in Korea. However, we recently experienced 17 cases of adult tetanus
in a university hospital during a 21-month period. Seventy percent of the patients
were female, and the mean age was 63 yr (range, 29-87). The majority (88.2%) of the
patients did not get primary vaccinations for tetanus and decennial tetanus-diph-
theria toxoid booster. Most patients (88.2%), who sustained acute injury, did not
seek medical care for their wounds or did not receive the prophylaxis for tetanus. Te-
tanus was found most frequently among farmers. Tetanus was diagnosed initially only
in 53% of patients. The case-fatality ratio was 23.5%. These cases show that recent-
ly occurring tetanus in Korea is a disease, affecting the elderly and the female who
may have a lower immunity against tetanus, and the farmers who are likely to be ex-
posed to Clostridium tetani. In addition, diagnosis of tetanus is often delayed in area
where cases are seen infrequently. Therefore, improved education among patients
and physicians, emphasis of anti-tetanus immunization and awareness of tetanus
respectively, may be essential for the prevention of disease and the reduction of its
mortality.
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females. All the cases were non-neonatal, adult tetanus. Of
these, all patients except one who was a 29-yr-old female who
was a housewife, and also a puerperal tetanus patient, were
farmers. We reported the case of puerperal tetanus patient pre-
viously (3). Out of the 17 patients with tetanus, 15 (88.2%)
patients did not get the primary vaccination for tetanus and de-
cennial tetanus-diphtheria toxoid booster, but two (11.7%)
patients had a primary vaccination series during the childhood
except decennial tetanus-diphtheria toxoid booster thereafter.
All the patients in this study developed tetanus during the
periods from March 2000 to November 2001, which usually
coincided with the warm season and the time of their most
intensive work in the fields.
Portals of entry and type of injury
An acute injury sustained before onset of tetanus was iden-
tified among the 16 (94.1%) tetanus cases with known injury
status. Portals of entry were an upper extremity in 8 (47.0%)
patients, a lower extremity (one patient had a burn wound on
back as well) in 6 (35.2%) and an oral cavity in 1 (5.8%). One
puerperal tetanus patient did not have a sustained acute wound,
but the disease occurred 9 days postpartum. In this case, the
genital tract might be the portal of entry. Of 17 cases, 4 (23.5%)
occurred after puncture wounds and abrasions, the most com-
mon types of injuries, respectively. The types of puncture wo-
unds were from cuts by rusty wire, or piece of wood, and from
stepping on nail or glass. Other most frequently reported types
of acute injuries were 3 (17.6%) lacerations, 3 (17.6%) wounds
including burn, and 1 (5.8%) patient had a toothache due to
odontitis and had tooth extracted. Additionally, two (11.7%)
patients applied home remedy, ground grass or tree to previ-
ous operation wound or wound due to ingrowing nail.
Fifteen (88.2%) patients, excluding one with whom tetanus
occurred after the delivery, and another one with odontitis, did
not seek for medical care for their wounds and did not received
prophylaxis for tetanus. They applied wound care for themselves
at home, because the wounds were mild and small in size.
Clinical features
The incubation period, which is the time between the injury
and the first clinical symptoms, varied from 2 to about 60 days.
In addition, the interval between first symptoms and gener-
alized spasms, period of onset, also varied from 1 to 10 days.
The clinical type of tetanus was generalized in all patients.
The first symptoms and signs were lockjaw, the most common
first symptom in 17 (100%) patients, swallowing difficulty
in12 (70.5%), dysarthria in 6 (35.2%), and neck stiffness in 5
(29.4%) patients.
Autonomic nervous dysfunctions were common. Of cardio-
vascular dysfunction, profound bradycardia or tachycardia were
in 3 patients; 1 sinus tachycardia occurred 1 day, 1 atrial fib-
rillation 2 days, and 1 ventricular tachycardia 5 days after onset
of symptoms. The patients with ventricular tachycardia received
cardiopulmonary resuscitation and antiarrhythmic drugs, but
other patients were restored spontaneously to normal sinus
rhythm without antiarrhythmic drugs. Also disordered blood
Patient
Age (yr),
Sex
Immunization
history
Portals of 
entry
Type of injury
Incubation
period (days)
Period of
onset (days)
Type
Treatment
ATB/IM/MV
Outcome
1
� 44, M No Foot, back Burn wound 11 6 G MTZ, IM, MV Die
2 71, F No Forearm Puncture (Rusty wire) Unknown 6 G MTZ, IM Survive
3 70, F No Finger Laceration (Scissors) 4 6 G MTZ, IM Survive
4 72, M No Foot Laceration (Saw) 5 <1 G MTZ, IM, MV Survive
5 56, F No Foot Puncture (Nail) 4 1 G MTZ, IM, MV Survive
6 71, F No Foot Puncture (Glass) 5 Unknown G MTZ, IM Survive
7
� 80, F No Forearm Abrasion (?) 9 5 G MTZ, IM Die
8 87, F No Wrist Abrasion (?) 18 7 G MTZ, IM Survive
9 29, F Partial Genital tract Delivery 9 5 G MTZ, IM Survive
10 32, M Partial Hand Puncture (Wood) 60 2 G MTZ, IM, MV Survive
11 77, M No Forearm Wound (Ground grass) 2 3 G MTZ, IM Die
12 72, F No Unknown Unknown Unknown Unknown G MTZ, IM Survive
13 75, F No Hand Abrasion (?) 10 7 G MTZ, IM, MV Survive
14 54, F No Lower extremity Abrasion (?) 20 10 G MTZ, IM Survive
15
� ,� 66, F No Finger Laceration (Knife) 43 2 G MTZ, IM, MV Die
16
� 56, M No Oral cavity Odontitis Unknown 8 G MTZ, IM Survive
17
� 56, F No Great toe Wound (Ground tree) 10 8 G MTZ, IM Survive
Table 1. Descriptions of 17 patients with tetanus
No, no history of primary vaccination for tetanus and decennial tetanus-diphthera toxoid booster; Partial, only primary vaccination for tetanus during
childhood; Incubation period, time between the injury and the first clinical symptoms; Period of onset, interval between first symptoms and general-
ized spasms; ATB, antibiotics, IM, passive & active immunization; MV, mechanical ventilation, MTZ, metronidazole; G, generalized; *, type of tetanus;
� , these patients were discharged against medical advice, who were not cared over the whole period of treatment. 
� , these patients did not received
DT because DT is not available in Korea since August 2002.Adult Tetanus in Korea 13
pressure was in 14 patients. Those cardiovascular dysfunctions
were recurrent and labile. Six patients, who had a mean peri-
od of onset 3.1 days (range, 1-7), developed laryngeal spasm
of sudden onset, progressed to respiratory failure and received
mechanical ventilation. In addition, sweating and increased
secretion were common. Other clinical manifestations were
presented in Table 2.
Complications were pneumonia in 5 patients, atelectasis in
4 patients, bacteremia (catheter-related) in 3 patients, joint
contracture in 3 patients, urinary tract infection in 2 patients,
and pressure sore in 2 patients.
Provisional diagnosis in emergency room
We reviewed the provisional diagnosis in order to find out
whether the physicians were aware of tetanus in emergency
room. Provisional diagnosis were tetanus in only 9 (53%) of
the 17 patients. The actual erroneous diagnoses by clinicians
included oromandibular dystonia, electrolyte imbalance, cer-
vical dystonia, meningitis, meningoencephalitis, hypertensive
encephalopathy, cerebral infarct, arthritis of temporomandibu-
lar joint, cerebral infarction and spinal cord injury.
Treatment and outcome
Of 17 patients, all patients received treatment such as TIG
(tetanus immunoglobulin, Hypertet
� 3000 IU, Green Cross,
Korea) and intravenous metronidazole (500 mg thrice daily).
However three patients did not receive the whole period of
treatment and was discharged or sent to other hospital. Since
Td (tetanus-diphtheria toxoid) was not available, DT (diph-
theria-tetanus toxoid, D.T. VAX
� 0.5 mL, Green Cross, Korea)
was subcutaneously administered for 14 patients on admission,
and for 11 out of 14 patients who received the whole period of
treatment on 1 month and 6 months after the first dose. They
were monitored in the quiet and dark room at which environ-
mental stimuli and unnecessary patient manipulation were
minimized. Patients with unstable vital signs were cared in
intensive care unit during the early stage. Benzodiazepines
were used for sedation. In addition, vasopressors or antihyper-
tensive agents were used for disordered blood pressure. In case
of patients with severe muscular rigidity and pain, muscular
blocking agent (vecuronium) was administered after the mech-
anical ventilation was applied. Six patients with respiratory
failure received ventilator therapy.
Four deaths occurred among 17 patients, including 3 patients
who were not cared over the whole period of treatment in our
hospital, representing a case-fatality ratio of 23.5%. Among
4 deaths, 3 result from patients who denied treatment in our
hospital and were discharged or sent to other hospital and 1
results from patient with intractable hypotension.
DISCUSSION
Tetanus is a fatal infectious disease, usually of acute onset,
which results from contamination of a wound with the tetanus
bacillus, Clostridium tetani. The clinical manifestations result
from a potent neurotoxin, tetanospasmin that produces painful
spasm and muscular rigidity. Vaccination with a primary series
of three doses of tetanus toxoid containing vaccine and boost-
er doses of Td (tetanus-diphtheria toxoid) every 10 yr are high-
ly effective in preventing tetanus (4).
During 1990-1999, a total of 8 tetanus cases have been re-
ported in Korea: 1 case in 1992, 3 cases in 1998, and 4 cases
in 1999 (5-7). A number which, due to passive reporting by
physicians, may underestimate the true rate of incidence of
the disease. In addition, the every 10-yr-booster of Td after
the primary tetanus-toxoid containing vaccine series have been
neglected in Korea because of unavailability of Td and lack of
education of adult vaccination. Therefore, the rate of occurrence
of tetanus may increase in Korea.
Our cases show that tetanus occurred more often among the
elderly females and males. The frequent occurrence of tetanus
among the elderly females and males may be due to the dif-
*, one patient had bradycardia and 5 tachycardia including atrial fibril-
lation and ventricular tachycardia in one each.
Clinical characteristic No. (%) of patients
First symptoms and signs
Lockjaw (trismus) 17 (100)
Swallowing difficulty 12 (70.5)
Neck stiffness 5 (29.4)
Dysarthria 6 (35.2)
Central nervous system symptoms
Seizure 2 (11.7)
Headache 5 (29.4)
Respiratory symptoms
Dyspnea 9 (52.9)
Laryngeal spasm 6 (35.2)
Respiratory failure 6 (35.2)
Cardiovascular symptoms
Chest pain 2 (11.7)
Arrhythmia* 5 (29.4)
Hypertension 12 (70.5)
Hypotension 2 (11.7)
Gastrointestinal symptoms
Nausea/vomiting 3 (17.6)
Paralytic ileus 6 (35.2)
Neuromuscular symptoms
Neck stiffness 14 (82.3)
Opisthotonus 11 (64.7)
Muscular spasm 17 (100)
Back pain 17 (100)
Rigid abdominal wall 12 (70.5)
Others
Sweating 11 (64.7)
Increased secretion 5 (29.4)
Fever 7 (41.1)
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ference of tetanus immunity by age and sex. In the U.S. study,
the prevalence of immunity declined rapidly at the age of 40
yr, and only 27.8% among those 70 yr of age or older had pro-
tective levels of tetanus antibodies. It also states that men had
significantly higher age-adjusted rates of immunity than wo-
men had, and in particular, large differences in the rates between
men and women at 40 yr of age or older accounted for most
of this gap (8). Similarly, among the Australian population,
52% of adults 49 yr of age or older had protective levels of
tetanus antitoxin. There also was a significant decline in the
prevalence of immunity with increasing age, and women were
less likely to be immune regardless of their age (9). A recent
population-based serologic survey of immunity to tetanus in
Korea may partially explain the frequent occurrence of tetanus
among the elderly females and males: the immunity to tetanus
remarkably decreased among the populations 30 yr of age or
older, of whom over 75% needed maintenance of immunity
to tetanus, and among populations greater than or equal to 60
yr, the immunity in male was significantly greater than in
female (10). In addition, the majority of Korean male, who
had records of military service, might have protective immu-
nity to tetanus. Therefore, the differences in the rate between
men and women were increasing with age, suggesting that
women were less likely to be immune (8-10).
Most patients in our study had an acute trauma sustained
before onset of tetanus. However they did not seek for med-
ical care for their wound, because their wounds were not con-
sidered severe. Thus, they did not have a chance to receive pro-
phylaxis against tetanus. In addition, 16 patients were farm-
ers who were likely to be exposed to the soils, a natural habi-
tat of C. tetani, and one patient was a housewife who did not
have an acute trauma except delivery occurred in the hospital
that used standard hygienic practices. Because C. tetani are
widely distributed in the environment, and are found in the
intestinal flora of domestic animals, horses, chickens, and hu-
mans, the genital tract may be a natural habitat for C. tetani.
The portals of entry described in our study are consistent with
the previous studies (11-13). However, even minor trauma can
lead to tetanus and in up to 30% of patients no portal of entry
is apparent (11, 12). These findings illustrate that there are no
safe wounds for tetanus. Therefore, the prevention for tetanus
requires carefully reviewed tetanus immunization status and
a full immunization for all visitors at health care centers.
The incubation period and period of onset are important
in prognosis; shorter these periods, more severe the disease
(14). In this study, six patients with period of onset 3.1 days
developed respiratory failure and required mechanical venti-
lation. Thus, a short period of onset may be associated with
requirement of ventilation.
Tetanospasmin, which C. tetani produces, exerts its effects
on the spinal cord, the brain stem, peripheral nerves, at neuro-
muscular junctions, and directly on muscles, with antago-
nizing inhibitory motor activity and also with stimulating the
autonomic nervous system (14, 15). Of four types: localized,
cephalic, neonatal or generalized, generalized tetanus is the
most common and presents with pain, headache, stiffness, rigid-
ity, opisthotonus and spasms, which can lead to laryngeal ob-
struction. Trismus (lockjaw)-the inability to open the mouth
fully owing to rigidity of masseters is often the first symptom.
In this study, 100% of patients experienced lockjaw, 70.5%
difficulty in swallowing, 35.2% dysarthria, and 29.4% neck
stiffness as the first symptoms and signs. As the disease pro-
gresses, spasms extend into other muscular groups including
back, abdomen, extremities or respiratory system, leading to
respiratory arrest, the commonest direct cause of death when
intubation and mechanical ventilation is not available. Six
patients who developed laryngeal spasm in our study required
prolonged mechanical ventilation, and two of six patients died;
one was discharged without complete treatment and another
died of intractable hypotension. In addition, autonomic distur-
bance with sustained labile hypertension, hypotension, tachy-
cardia, bradycardia, dysrhythmia and increased secretion are
recurrent, labile in severe cases (16). In particular, these cardio-
vascular manifestations do not usually occur until later in the
course of the disease and is associated with a poor prognosis
(17, 18). In our study, a total of five patients developed arrhyth-
mia within 5 days after onset of symptoms and one patient died
of hypotension.
The common complications in our study, such as pneumo-
nia, atelectasis, catheter-related bacteremia, joint contracture,
urinary tract infection and pressure sores may be attributable
to increased bronchial secretion, intensive care and prolonged
periods of immobility. Much attention must be paid to pre-
venting those complications and detail in basic care.
The diagnosis is based on clinical features. Because of the
rarity of tetanus, as well as the similarity of its clinical man-
ifestations to other more common medical conditions, the di-
agnosis is difficult and is often a diagnosis of exclusion. The
differential diagnosis of tetanus should be extensive; hypocal-
cemia, hypoglycemia, strychnine poisoning, drug induced dys-
tonic reactions, rabies, orofacial infection, meningitis, seizures
and meningoencephalitis (14). In our study, only 53% of pa-
tients were diagnosed with tetanus initially in emergency room.
Early diagnosis and aggressive management are to be imple-
mented in order to reduce the mortality of tetanus patients.
Thus, increased awareness and education regarding tetanus
among physicians should be emphasized.
There is no curative treatment for tetanus. If tetanus is sus-
pected, aggressive management should be implemented as
early as possible. All tetanus patients should be cared in a mon-
itored room that is dark and quiet. Environmental stimuli, as
well as unnecessary patient manipulation, should be minimized.
Tetanus patients may often require ventilatory support because
of asphyxia from increased secretion and continual muscle spa-
sms. In our study, six patients progressed to respiratory fail-
ure and received mechanical ventilation. If the hypersympa-
thetic state such as hypertension, and tachycardia happened,
early attempts to control autonomic disturbance included and  -adrenoceptor blockers and combined block either with
propranolol or labetolol (14). Large doses of sedatives such as
benzodiazepines may be necessary to control muscular spasms
and tetanic seizures. Tetanic spasms refractory to benzodia-
zepines may be managed with nondepolarizing neuromus-
cular blocking agents such as vecuronium.
Passive immunization with human tetanus immunoglob-
ulin (HTIG) should be given intramuscularly as soon as pos-
sible, proven that early administrations are associated with
decreased mortality. Once the toxin is bound and internalized
it will have no effect (19). When 3000 IU are administered
intramuscularly, maximum concentrations reach in 24-48 hr
and approximately 0.1 IU/mL. Adequate concentrations of
passive antitoxin that protect a human against tetanus are main-
tained for 10-15 days (14). Patients with tetanus also should
actively be immunized through administration of adsorbed
tetanus toxoid given intramuscularly at a site contralateral to
the HTIG dosing. In our study, DT were administered to the
patients instead of Td, which was not available in Korea. Vac-
cination with lower dose of DT (0.25 mL) induced an excel-
lent immune response (20, 21). All adults should be immune
to tetanus and if not previously immunized they should be
given a primary immunizing course (three doses of Td admin-
istered at time zero, 4 to 8 weeks, and 6 to 12 months) with
boosters administered every 10 yr thereafter (22).
In patients with a deep wound, thorough debridement and
toilet, and antibiotic therapy are critical to remove the source
of toxin production. Metronidazole is a safe alternative to peni-
cillin because penicillin can cause CNS hyperexcitability and
may be now considered as the first line therapy (23). The dose
is 500 mg every 6 hr intravenously for 7-10 days.
There were four deaths with the case-fatality rate of 23.5%
in our study. In the U.S. studies, the case-fatality rate of 11-
25% was reported and increased with age (12, 24). In partic-
ular, total of three patients who did not receive the whole peri-
od of treatment in our study died. Thus all tetanus patients
always require the intensive treatment.
Only 11.7% of tetanus patients in our study have received
a primary series of tetanus-toxoid containing vaccine, and all
patients did not have a booster within 10 yr before onset of
tetanus. This finding is similar to that seen at the previous
studies (12, 24). Therefore, to reduce the tetanus burden among
older adults, the necessity for the every 10-yr-booster of Td
after the primary tetanus-toxoid containing vaccine series should
be emphasized.
Our study is limited because of the small number of patients,
diagnosis only based on clinical features, and incomplete treat-
ment for 3 patients who were discharged or sent to other hos-
pital.
In summary, our cases show that tetanus has still become
a disease of the elderly and inadequately immunized persons
in Korea. Most tetanus patients had acute injury sustained
before onset of tetanus, but did not receive tetanus prophylax-
is such as anti-tetanus immunoglobulin and/or tetanus vac-
cination. Therefore, every contact with a potential patient at
risk should prompt a careful review of tetanus immunization
status and ensure full immunization for prevention of tetanus.
In addition, increased awareness and education regarding te-
tanus among physicians are essential for recognizing tetanus
along with aggressive management in the early stages.
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